Literature DB >> 34461619

The Treatment of Obesity in Cardiac Rehabilitation: A REVIEW AND PRACTICAL RECOMMENDATIONS.

Philip A Ades1, Patrick D Savage.   

Abstract

BACKGROUND: Cardiac rehabilitation (CR) programs have evolved from exercise-only programs designed to improve cardiorespiratory fitness to secondary prevention programs with a broader mandate to alter lifestyle-related behaviors that control cardiac risk factors and, thereby, reduce overall cardiovascular risk. As the obesity epidemic has evolved in the late 20th and early 21st centuries, the prevalence of type 2 diabetes mellitus and the metabolic syndrome have soared and blunted the otherwise expected downturn in deaths from coronary heart disease related to better control of risk factors. In that the causes of obesity are behavioral in origin, the most effective treatment strategy requires a comprehensive, behavioral-based approach.
PURPOSE: In this review, we outline optimal lifestyle approaches that can be delivered in the CR setting to assist cardiac patients with their long-term goals of reducing weight and improving cardiac risk factors while concurrently improving cardiorespiratory fitness. We also performed a survey of CR program throughout the United States and found that only 8% currently deliver a behavioral weight programs.
CONCLUSIONS: Cardiac rehabilitation programs need to take on an important challenge of secondary prevention, which is to develop behavioral weight loss programs to assist cardiac patients to lose weight and, thereby, improve multiple risk factors and long-term prognosis.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34461619      PMCID: PMC8522194          DOI: 10.1097/HCR.0000000000000637

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   3.646


  55 in total

1.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus
Journal:  Crit Pathw Cardiol       Date:  2005-12

Review 2.  Role of Physical Activity and Exercise in Treating Patients with Overweight and Obesity.

Authors:  John M Jakicic; Renee J Rogers; Kelliann K Davis; Katherine A Collins
Journal:  Clin Chem       Date:  2017-11-20       Impact factor: 8.327

3.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

4.  Clinical and Demographic Trends in Cardiac Rehabilitation: 1996-2015.

Authors:  Diann E Gaalema; Patrick D Savage; Kevin Leadholm; Jason Rengo; Shelly Naud; Jeffrey S Priest; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-07       Impact factor: 2.081

5.  Caloric expenditure during cardiac rehabilitation.

Authors:  J R Schairer; T Kostelnik; S M Proffitt; K I Faitel; S Windeler; L B Rickman; C A Brawner; S J Keteyian
Journal:  J Cardiopulm Rehabil       Date:  1998 Jul-Aug       Impact factor: 2.081

6.  Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index.

Authors:  Justo Sierra-Johnson; Abel Romero-Corral; Virend K Somers; Francisco Lopez-Jimenez; Randal J Thomas; Ray W Squires; Thomas G Allison
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2008-06

7.  American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults.

Authors:  Joseph E Donnelly; Steven N Blair; John M Jakicic; Melinda M Manore; Janet W Rankin; Bryan K Smith
Journal:  Med Sci Sports Exerc       Date:  2009-02       Impact factor: 5.411

8.  Importance of Lifestyle Modification on Cardiovascular Risk Reduction: COUNSELING STRATEGIES TO MAXIMIZE PATIENT OUTCOMES.

Authors:  Barry A Franklin; Jonathan Myers; Peter Kokkinos
Journal:  J Cardiopulm Rehabil Prev       Date:  2020-05       Impact factor: 2.081

9.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

10.  Once-Weekly Semaglutide in Adults with Overweight or Obesity.

Authors:  John P H Wilding; Rachel L Batterham; Salvatore Calanna; Melanie Davies; Luc F Van Gaal; Ildiko Lingvay; Barbara M McGowan; Julio Rosenstock; Marie T D Tran; Thomas A Wadden; Sean Wharton; Koutaro Yokote; Niels Zeuthen; Robert F Kushner
Journal:  N Engl J Med       Date:  2021-02-10       Impact factor: 91.245

View more
  2 in total

Review 1.  Prevalence, Impact, and Trajectories of Sleep Disturbance in Cardiac Rehabilitation: A NARRATIVE REVIEW AND SUGGESTIONS FOR EVALUATION AND TREATMENT.

Authors:  Caitlan A Tighe; Daniel J Buysse; Debra K Weiner; Gregory P Beehler; Daniel E Forman
Journal:  J Cardiopulm Rehabil Prev       Date:  2022-05-02       Impact factor: 3.646

2.  Change in Metabolic Syndrome and Cardiorespiratory Fitness Following Exercise Training - The Ball State Adult Fitness Longitudinal Lifestyle Study (BALL ST).

Authors:  Brittany E Smith; James E Peterman; Matthew P Harber; Mary T Imboden; Bradley S Fleenor; Leonard A Kaminsky; Mitchell H Whaley
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-20       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.